Full Text View
Tabular View
No Study Results Posted
Related Studies
rhEndostatin Protein Involving Pediatric Patients With Cancer
This study has been terminated.
( Lack of drug supply )
Study NCT00165373   Information provided by Dana-Farber Cancer Institute

First Received on September 9, 2005.   Last Updated on December 21, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumors
Interventions listed in this trial
rhEndostatin
Additional drug interventions recognized in this trial
Endostatins
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Dana-Farber Cancer Institute
Children's Hospital Boston


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services